How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
58
TWST Quote, Financials, Valuation and Earnings
Last price:
$49.22
Seasonality move
:
-14.76%
Day range:
$47.00 - $49.72
52-week range:
$23.30 - $54.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.62x
P/B ratio:
6.62x
Volume:
2.1M
Avg. volume:
1.4M
1-year change:
-8.31%
Market cap:
$3B
Revenue:
$376.6M
EPS (TTM):
-$1.27
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$102M | -$0.52 | 16.09% | -19.61% | $49.89 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.13% | 54.83% | $133.11 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ENOV
Enovis Corp.
|
$582.4M | $0.84 | 4.29% | 1731.46% | $45.09 |
|
LFWD
Lifeward Ltd.
|
$7.9M | -$0.09 | 4.27% | -94.81% | $7.25 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$49.24 | $49.89 | $3B | -- | $0.00 | 0% | 7.62x |
|
ABT
Abbott Laboratories
|
$110.83 | $133.11 | $192.7B | 29.93x | $0.63 | 2.17% | 4.37x |
|
ARAY
Accuray, Inc.
|
$0.62 | $2.53 | $70.3M | 149.00x | $0.00 | 0% | 0.16x |
|
ENOV
Enovis Corp.
|
$22.59 | $45.09 | $1.3B | -- | $0.00 | 0% | 0.57x |
|
LFWD
Lifeward Ltd.
|
$0.57 | $7.25 | $10.1M | -- | $0.00 | 0% | 0.27x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.26 | $5.50 | $35.7M | -- | $0.00 | 0% | 4.17x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
17.69% | 0.525 | 5.04% | 3.09x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 186.42% | 0.52x |
|
ENOV
Enovis Corp.
|
41.63% | 0.357 | 82.96% | 0.86x |
|
LFWD
Lifeward Ltd.
|
1.82% | -2.141 | 1.98% | 0.94x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$54M | -$32.9M | -14.09% | -16.63% | -31.73% | -$34.8M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | $8.4M |
|
ENOV
Enovis Corp.
|
$286.7M | $9M | -33.65% | -52.07% | 1.65% | $29.1M |
|
LFWD
Lifeward Ltd.
|
$2.7M | -$3.1M | -146.07% | -150.63% | -50.69% | -$3.8M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
Twist Bioscience Corp. vs. Competitors
-
Which has Higher Returns TWST or ABT?
Abbott Laboratories has a net margin of -29.42% compared to Twist Bioscience Corp.'s net margin of 15.5%. Twist Bioscience Corp.'s return on equity of -16.63% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.52.05% -$0.50 $554.1M ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About TWST or ABT?
Twist Bioscience Corp. has a consensus price target of $49.89, signalling upside risk potential of 1.32%. On the other hand Abbott Laboratories has an analysts' consensus of $133.11 which suggests that it could grow by 20.11%. Given that Abbott Laboratories has higher upside potential than Twist Bioscience Corp., analysts believe Abbott Laboratories is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.7 2 0 ABTAbbott Laboratories15 7 0 -
Is TWST or ABT More Risky?
Twist Bioscience Corp. has a beta of 2.240, which suggesting that the stock is 124.046% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock TWST or ABT?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.17% to investors and pays a quarterly dividend of $0.63 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TWST or ABT?
Twist Bioscience Corp. quarterly revenues are $103.7M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. Twist Bioscience Corp.'s net income of -$30.5M is lower than Abbott Laboratories's net income of $1.8B. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 29.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 7.62x versus 4.37x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.7.62x -- $103.7M -$30.5M ABTAbbott Laboratories4.37x 29.93x $11.5B $1.8B
-
Which has Higher Returns TWST or ARAY?
Accuray, Inc. has a net margin of -29.42% compared to Twist Bioscience Corp.'s net margin of -13.47%. Twist Bioscience Corp.'s return on equity of -16.63% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.52.05% -$0.50 $554.1M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About TWST or ARAY?
Twist Bioscience Corp. has a consensus price target of $49.89, signalling upside risk potential of 1.32%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 307.26%. Given that Accuray, Inc. has higher upside potential than Twist Bioscience Corp., analysts believe Accuray, Inc. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.7 2 0 ARAYAccuray, Inc.2 0 0 -
Is TWST or ARAY More Risky?
Twist Bioscience Corp. has a beta of 2.240, which suggesting that the stock is 124.046% more volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock TWST or ARAY?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or ARAY?
Twist Bioscience Corp. quarterly revenues are $103.7M, which are larger than Accuray, Inc. quarterly revenues of $102.2M. Twist Bioscience Corp.'s net income of -$30.5M is lower than Accuray, Inc.'s net income of -$13.8M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 7.62x versus 0.16x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.7.62x -- $103.7M -$30.5M ARAYAccuray, Inc.0.16x 149.00x $102.2M -$13.8M
-
Which has Higher Returns TWST or ENOV?
Enovis Corp. has a net margin of -29.42% compared to Twist Bioscience Corp.'s net margin of -104%. Twist Bioscience Corp.'s return on equity of -16.63% beat Enovis Corp.'s return on equity of -52.07%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.52.05% -$0.50 $554.1M ENOVEnovis Corp.52.24% -$9.99 $3.5B -
What do Analysts Say About TWST or ENOV?
Twist Bioscience Corp. has a consensus price target of $49.89, signalling upside risk potential of 1.32%. On the other hand Enovis Corp. has an analysts' consensus of $45.09 which suggests that it could grow by 99.61%. Given that Enovis Corp. has higher upside potential than Twist Bioscience Corp., analysts believe Enovis Corp. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.7 2 0 ENOVEnovis Corp.9 1 0 -
Is TWST or ENOV More Risky?
Twist Bioscience Corp. has a beta of 2.240, which suggesting that the stock is 124.046% more volatile than S&P 500. In comparison Enovis Corp. has a beta of 1.285, suggesting its more volatile than the S&P 500 by 28.492%.
-
Which is a Better Dividend Stock TWST or ENOV?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Enovis Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Enovis Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or ENOV?
Twist Bioscience Corp. quarterly revenues are $103.7M, which are smaller than Enovis Corp. quarterly revenues of $548.9M. Twist Bioscience Corp.'s net income of -$30.5M is higher than Enovis Corp.'s net income of -$570.9M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Enovis Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 7.62x versus 0.57x for Enovis Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.7.62x -- $103.7M -$30.5M ENOVEnovis Corp.0.57x -- $548.9M -$570.9M
-
Which has Higher Returns TWST or LFWD?
Lifeward Ltd. has a net margin of -29.42% compared to Twist Bioscience Corp.'s net margin of -51.17%. Twist Bioscience Corp.'s return on equity of -16.63% beat Lifeward Ltd.'s return on equity of -150.63%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.52.05% -$0.50 $554.1M LFWDLifeward Ltd.43.7% -$0.20 $13M -
What do Analysts Say About TWST or LFWD?
Twist Bioscience Corp. has a consensus price target of $49.89, signalling upside risk potential of 1.32%. On the other hand Lifeward Ltd. has an analysts' consensus of $7.25 which suggests that it could grow by 1171.93%. Given that Lifeward Ltd. has higher upside potential than Twist Bioscience Corp., analysts believe Lifeward Ltd. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.7 2 0 LFWDLifeward Ltd.1 0 0 -
Is TWST or LFWD More Risky?
Twist Bioscience Corp. has a beta of 2.240, which suggesting that the stock is 124.046% more volatile than S&P 500. In comparison Lifeward Ltd. has a beta of 0.161, suggesting its less volatile than the S&P 500 by 83.916%.
-
Which is a Better Dividend Stock TWST or LFWD?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifeward Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Lifeward Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or LFWD?
Twist Bioscience Corp. quarterly revenues are $103.7M, which are larger than Lifeward Ltd. quarterly revenues of $6.2M. Twist Bioscience Corp.'s net income of -$30.5M is lower than Lifeward Ltd.'s net income of -$3.2M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Lifeward Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 7.62x versus 0.27x for Lifeward Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.7.62x -- $103.7M -$30.5M LFWDLifeward Ltd.0.27x -- $6.2M -$3.2M
-
Which has Higher Returns TWST or PSTV?
Plus Therapeutics, Inc. has a net margin of -29.42% compared to Twist Bioscience Corp.'s net margin of -316.61%. Twist Bioscience Corp.'s return on equity of -16.63% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.52.05% -$0.50 $554.1M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About TWST or PSTV?
Twist Bioscience Corp. has a consensus price target of $49.89, signalling upside risk potential of 1.32%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 2016.2%. Given that Plus Therapeutics, Inc. has higher upside potential than Twist Bioscience Corp., analysts believe Plus Therapeutics, Inc. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.7 2 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is TWST or PSTV More Risky?
Twist Bioscience Corp. has a beta of 2.240, which suggesting that the stock is 124.046% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock TWST or PSTV?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or PSTV?
Twist Bioscience Corp. quarterly revenues are $103.7M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Twist Bioscience Corp.'s net income of -$30.5M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 7.62x versus 4.17x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.7.62x -- $103.7M -$30.5M PSTVPlus Therapeutics, Inc.4.17x -- $1.4M -$4.4M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
